New Report: Average Annual Natural Catastrophe Losses for the Insurance Industry Reaches New High of $151 Billion
Globe Newswire3-09-2024, 15:00
Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer 29-06-2023, 12:59